| Literature DB >> 30037195 |
Safdar Ali Shaikh1, Amber Bawa1, Noman Shahzad2, Zara Yousufzai1, Muhammad Shahab Ghani1.
Abstract
BACKGROUND: The radial forearm free flap (RFFF) has remained a leading choice of many plastic surgeons as a fasciocutaneous flap due to its versatility, pedicle length, and simple elevation technique. However, donor site morbidity has led many reconstructive surgeons to limit their use of the RFFF and to use other flaps instead. We propose that using a narrow RFFF (nRFFF) decreases the aesthetic and functional morbidity of the donor site.Entities:
Keywords: Cicatrix, hypertrophic; Free tissue flaps; Reconstructive surgery
Year: 2018 PMID: 30037195 PMCID: PMC6062702 DOI: 10.5999/aps.2018.00115
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
Fig. 1.Long and narrow radial forearm free flap
(A) Free flap as dissected initially. (B) Flap rolled onto itself.
Stony Brook Scar Evaluation Scale
| Scar category | No. of point[ |
|---|---|
| Width, mm | |
| > 2 | 0 |
| ≤ 2 | 1 |
| Height | |
| Elevated or depressed in relation to surrounding skin | 0 |
| Flat | 1 |
| Color | |
| Darker than surrounding skin (red, purple, brown, or black) | 0 |
| Same color or lighter than surrounding skin | 1 |
| Hatch marks or suture marks | |
| Present | 0 |
| Absent | 1 |
| Overall appearance | |
| Poor | 0 |
| Good | 1 |
Total score=sum of individual scores; range, 0 (worst) to 5 (best).
Categories of aesthetic outcomes based on the Stony Brook Scar Evaluation Scale score
| Category | Stony Brook Scar Evaluation Scale score |
|---|---|
| Poor | ≤ 1 |
| Fair | 2 |
| Good | 3 |
| Very good | 4 |
| Excellent | 5 |
Sites of reconstruction
| Sites | No. of cases |
|---|---|
| Intraoral cheek | 15 |
| Tongue+floor of mouth | 4 |
| Palate | 1 |
| Cheek with angle of mouth | 1 |
| Gingivobuccal sulcus | 1 |
| Retromolar fossa | 1 |
| Lower lip | 1 |
Details regarding defect size, flap size, and recipient vessels
| No. | Sex | Age (yr) | Site | Defect size (cm) | Flap size (cm) | Primary site closed | Recipient vessels |
|---|---|---|---|---|---|---|---|
| 1 | Male | 46 | Intraoral cheek | 5 × 6.5 | 2.5 × 13 | Yes | FA+CFV+EJV |
| 2 | Male | 54 | Intraoral cheek | 6 × 6 | 3 × 12 | Yes | STA+CFV+EJV |
| 3 | Male | 50 | Palate | 4 × 4 | 2 × 8 | Yes | STA+IJV |
| 4 | Male | 55 | Tongue | 7 × 10 | 3.5 × 20 | Yes | STA+CFV+IJV |
| 5 | Male | 50 | Tongue+floor of mouth | 5 × 5 | 2.5 × 10 | Yes | FA+IJV+EJV |
| 6 | Male | 65 | Intraoral cheek | 5 × 4.5 | 2.5 × 9 | Yes | STA+CFV |
| 7 | Male | 39 | Intraoral cheek | 4 × 6 | 2 × 12 | Yes | STA+CFV+EJV |
| 8 | Male | 55 | Intraoral cheek | 5 × 5 | 2.5 × 10 | Yes | FA+EJV+CFV |
| 9 | Female | 58 | Oral mucosa of the cheek and angle of mouth | 5 × 6.5 | 2.5 × 13 | Yes | FA+IVJ |
| 10 | Male | 40 | Intraoral cheek+floor of mouth | 4 × 9 | 2 × 18 | Yes | FA+IJV |
| 11 | Male | 55 | Intraoral cheek+lip | 4 × 9 | 2 × 18 | Yes | FA+IJV |
| 12 | Male | 54 | Intraoral cheek | 4 × 6.5 | 2 × 13 | Yes | STA+IJV+EJV |
| 13 | Male | 35 | Intraoral cheek | 1.5 × 8 | 3 × 16 | Yes | FA+IJV+EJV |
| 14 | Female | 65 | Intraoral cheek | 5 × 5 | 2.5 × 10 | Yes | FA+IJV+CFV |
| 15 | Male | 52 | Intraoral cheek | 5 × 5 | 2.5 × 10 | No | STA+IJV |
| 16 | Male | 51 | Intraoral cheek | 4 × 8 | 2 × 16 | Yes | STA+CFV+EJV |
| 17 | Female | 53 | Gingivobuccal sulcus | 5 × 6 | 2.5 × 12 | Yes | STA+CFV+IJV |
| 18 | Female | 34 | Tongue | 4 × 5 | 2 × 10 | Yes | FA+IJV |
| 19 | Male | 46 | Intraoral cheek | 5 × 6 | 2.5 × 12 | Yes | FA+IJV |
| 20 | Male | 58 | Intraoral cheek | 4 × 6 | 2 × 12 | Yes | FA+CFV+EJV |
| 21 | Male | 30 | Intraoral cheek | 4.5 × 6.5 | 2 × 6 + 2.5 × 7 | Yes | STA+CFV |
| 22 | Male | 40 | Tongue | 4.5 × 7 | 2 × 7 + 2.5 × 7 | Yes | STA+IJV |
| 23 | Male | 60 | Intraoral cheek | 3.6 × 7 | 1.8 × 14 | Yes | FA+IJV |
| 24 | Male | 32 | Intraoral cheek | 5 × 7 | 2.5 × 14 | Yes | STA+CFV+EJV |
FA, facial artery; CFV, common facial vein; EJV, external jugular vein; STA, superior thyroid artery; IJV, internal jugular vein.
Aesthetic outcomes of the patients according to the Stony Brook Scar Evaluation Scale
| Category | Patients |
|---|---|
| Excellent | 4 (16.6) |
| Very good | 8 (33.3) |
| Good | 10 (41.6) |
| Fair | 2 (8.3) |
| Poor | - |
| Total | 24 (100) |
Values are presented as number (%).
Fig. 2.Cheek carcinoma managed by a nRFFF
(A) Squamous cell carcinoma of the left cheek. (B) Marking of the narrow radial forearm free flap (nRFFF). (C) The nRFFF at 3 months postoperatively. (D) The donor site scar at 3 months postoperatively.
Fig. 3.Tongue carcinoma managed by a nRFFF
(A) Squamous cell carcinoma of the tongue. (B) Marking of the narrow radial forearm free flap (nRFFF). (C) The nRFFF at 2 months postoperatively. (D) The donor site scar after 2 months.